Sign Up to like & get
recommendations!
1
Published in 2022 at "mAbs"
DOI: 10.1080/19420862.2021.2024642
Abstract: ABSTRACT Although therapeutically efficacious, ipilimumab can exhibit dose-limiting toxicity that prevents maximal efficacious clinical outcomes and can lead to discontinuation of treatment. We hypothesized that an acidic pH-selective ipilimumab (pH Ipi), which preferentially and reversibly…
read more here.
Keywords:
selective antibody;
therapeutic index;
improved therapeutic;
acidic selective ... See more keywords